Sanofi, GlaxoSmithKline score EU supply pact for 300M coronavirus shots kblankenship Fri, 09/18/2020 – 08:50

FiercePharmaAsia—Takeda’s cell therapy center; Celltrion’s COVID-19 antibody; Dr. Reddy’s Revlimid deal aliu Fri, 09/18/2020 – 04:29

A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal […]

Face masks have become an important tool in fighting against the COVID-19 pandemic. However, improper use or disposal […]

The 2012 Health and Social Care Act was the largest ever reorganisation of the English NHS.1 It attracted […]

Politicians are better than doctors or scientists at medical education. Leaders such as Donald Trump, Vladimir Putin, Alexander […]

The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC

Tumour agnostic therapy demonstrates sustained efficacy

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)